Hologic AI Mammography Shows Promise in Detecting Invasive Lobular Cancer
Event summary
- Hologic presented new research at the SBI Symposium showing its Genius AI Detection solution identified 90% of invasive lobular cancer cases in a retrospective study.
- The study reviewed 239 cases of invasive lobular cancer diagnosed over a 10-year period at Massachusetts General Hospital.
- AI also flagged 43% of cases initially interpreted as negative during routine screening.
- Hologic also showcased its 3DQuorum imaging technology, which uses AI to reduce the number of 3D imaging slices radiologists need to review.
The big picture
Hologic's latest research underscores the growing role of AI in early cancer detection, particularly for subtypes that are harder to identify with traditional methods. As global breast cancer rates are expected to climb, the ability to detect these cancers earlier could be a significant differentiator in the women's health sector. The company's focus on AI-driven solutions aligns with broader industry trends toward more precise and efficient diagnostic tools.
What we're watching
- Clinical Validation
- Whether Hologic can replicate these results in real-time clinical practice and demonstrate measurable improvements in recall rates and biopsy outcomes.
- Market Adoption
- The pace at which radiology practices adopt AI-powered mammography solutions, particularly for challenging cancer subtypes like invasive lobular carcinoma.
- Competitive Dynamics
- How Hologic's AI advancements position it against competitors in the breast cancer detection space, especially as global breast cancer cases are projected to rise.